FdaApplication
NDA 216185
Identifiers
- fda_app_no: NDA216185
Properties
| Property | Value |
|---|---|
| applicant_name | AUCTA PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2023-05-04 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MOTPOLY XR | LACOSAMIDE | 150MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MOTPOLY XR | LACOSAMIDE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MOTPOLY XR | LACOSAMIDE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
3 products